YT521-B is a ubiquitously expressed nuclear protein that changes alternative splice site usage in a concentration dependent manner. YT521-B is located in a dynamic nuclear compartment, the YT body. We show that YT521-B is tyrosine phosphorylated by c-Abl in the nucleus. The protein shuttles between nucleus and cytosol, where it can be phosphorylated by c-Src or p59
INTRODUCTION
The eukaryotic nucleus contains a large number of specialized domains, such as nucleoli, speckles, Cajal bodies, PML bodies, Gems, SAM68 nuclear bodies and YT bodies (1) . Analysis of living cells has revealed that most of these structures are dynamic and often exchange proteins. For example, phosphorylation of pre-mRNA splicing factors causes their release into the nucleoplasm (2) . Speckles are dynamic structures (3) and often associate with sites of active transcription (4) . In this and other cases, the nuclear structure reflects the function and vice versa (5) .
YT521-B is a ubiquitously expressed nuclear protein that was discovered through the association of its glutamic-acid/ arginine-rich carboxy domain with splicing factors (6, 7) . YT521-B defines a novel compartment in the nucleus, the YT body. YT bodies contain sites of active transcription and are in close proximity to speckles and SAM68 nuclear bodies, which contain proteins interacting with YT521-B. YT bodies are dynamic structures that disappear during mitosis and are most pronounced in G1. When all three RNA polymerases are blocked by high concentrations of actinomycin D, YT bodies disperse throughout the nucleoplasm and accumulate in an unsoluble nuclear fraction, which distinguishes them from other nuclear subcompartments. The interaction of YT521-B with other nuclear proteins, such as SAM68 is regulated by tyrosine phosphorylation emanating from src kinases (7) .
YT521-B can change splice site selection in vivo in a concentration dependent manner (7) , either by sequestering splicing factors via protein -protein interaction or by directly binding to nucleic acids via its YTH domain (8) . The sequencing of the human genome has demonstrated that humans contain only about 25 000 genes, which is far less than previously expected. Therefore, the generation of protein isoforms through regulated alternative splicing is an important step in the gene expression of complex organisms. The majority of human genes are alternatively spliced. Estimates of the frequency of alternative splicing range between 47% based on EST comparisons and 74% based on exon junction microarrays (9, 10) . The exact mechanism leading to splice site selection is not fully understood (11) . It appears that splice site selection occurs concomitant with transcription (12) by formation of a protein -RNA network of regulatory factors binding both to highly degenerate sequences on the pre-mRNA and to other regulatory factors. This protein Human Molecular Genetics, Vol. 13, No. 15 # Oxford University Press 2004; all rights reserved { The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors. *To whom correspondence should be addressed. Tel: þ49 91318524622; Fax: þ49 91318524605; Email: stefan@stamms-lab.net complex brings splice sites in close vicinity which allows their recognition by the spliceosome (11, 13, 14) . Splice site recognition is a dynamic process, requiring constant building and release of individually weak molecular interactions. As a consequence, splice site selection is achieved by combinatorial control of protein concentration and interactions (15, 16) and is sensitive to sequestration of regulatory proteins (17) .
Alternative splicing patterns can change significantly between tissues, developmental stages (18) during tumorigenesis (19) or other cellular transformation (20) . In a single cell type, alternative splicing patterns can change in response to a change of environment, such as cellular stress (21, 22) , ischemia (23) , nutritional status (24) , neuronal activity (25 -27) or receptor stimulation (28 -30) (reviewed in 31). Sequence elements shared by different alternative exons indicate that environmental induced changes might be coordinated (32) .
The stimulation of receptor tyrosine kinases can result in a change in splice site selection (28,33 -36) . With the exception of the CD44 model, where the signal was shown to be mediated by the ras-pathway (29) , the connection between tyrosine phosphorylation and the spliceosome remains elusive. An increasing number of nuclear proteins were shown to be tyrosine phosphorylated and several tyrosine kinases and phosphatases are present in the nucleus (37) , but the function of the phosphorylation is mostly unknown. Here we show that the nuclear protein YT521-B shuttles between the nucleus and the cytosol, where it is phosphorylated by SRC and TEC tyrosine kinase family members. Furthermore, YT521-B colocalizes with c-Abl in the nucleus and is tyrosine phosphorylated by c-Abl. Phosphorylation results in a translocation of the phosphorylated protein from nuclear YT bodies to the nucleoplasm and its association with an unsoluble nuclear fraction. YT521-B loses its ability to change splice site selection of the IL-4 receptor, CD44 and SRp20 pre-mRNA after phosphorylation, which is most likely due to its sequestration in an unsoluble, inactive state.
RESULTS

YT521-B is phosphorylated on tyrosine residues
YT521-B is a nuclear protein composed of several domains: four nuclear localization signals, a glutamic acid rich region of unknown function, the YTH domain that possibly binds nucleic acids, a proline rich domain containing putative SH3 domain binding sites and a glutamic acid/arginine-rich region involved in protein -protein interaction (7, 8) (Fig. 1A) . We have previously shown that protein -protein interactions between YT521-B and Sam68 are regulated by tyrosine phosphorylation and demonstrated that p59 fyn causes phosphorylation of both proteins (7) . Since YT521-B is detected only in the nucleus (8), we asked whether other non-receptor tyrosine kinases whose expression is often not only confined to the cell membrane can cause its phosphorylation (38) . The sequencing of the human genome has demonstrated that humans possess 90 unique tyrosine kinases. Thirty-two of them are non-receptor type kinases which can be subdivided into 10 subfamilies (39) . In unstimulated cells, the activity of the endogenous kinases can only be detected using phosphorylation-specific antibodies against specific target sites. To test the result of kinase activation, we increased their activity by transfecting cDNAs expressing the kinases. Previous studies of YT521-B were performed in HEK293 cells (6, 7, 40) and we used these cells to allow for comparison of the data. A member of each subfamily was cotransfected with EGFP-YT521-B. After immunoprecipitation, tyrosine phosphorylation of YT521-B was detected by western blot using the phosphotyrosine specific antibody PY20. As shown in Figure 1B , the kinases c-Abl, Rlk, p59 fyn and c-Src, as members of the ABL, TEC and SRC families, phosphorylate YT521-B, whereas the related kinases Csk, FerH, Sik, Lyn and Syk, representing the CSK, FES, FRK and SYK families, had no effect. Similarly, Ack1, Ptk2 and Jtk1, representing the ACK, FAK and JTK families, did not phosphorylate YT521-B (data not shown). Reblotting (Fig. 1C) of the immunoprecipitates demonstrated the presence of YT521-B in all experiments, suggesting a specific action of c-Abl, Rlk, p59 fyn and c-Src. The kinases that did not phosphorylate YT521-B were active, as demonstrated by their ability to phosphorylate unknown proteins in cellular lysates (Fig. 1D) . Together, our data show that YT521-B is phosphorylated by specific nonreceptor tyrosine kinases.
YT521-B binds to c-Src and c-Abl kinases
Both c-Abl and Rlk phosphorylate YT521-B and can be located in the nucleus (41, 42) . Whereas c-Abl is expressed ubiquitously (43) , Rlk expression is confined predominantly to T-lymphocytes (42) . In contrast, c-Src and p59 fyn are ubiquitously expressed and located at the plasma membrane, although nuclear p59 fyn localization was observed during zebrafish development (44) . We therefore investigated whether there is a direct molecular interaction between YT521-B and nuclear or membrane bound tyrosine kinases and tested whether YT521-B would coimmunoprecipitate with c-Abl or c-Src as ubiquitously expressed examples. First, we expressed FLAG-YT521-B in the presence of c-Abl and immunoprecipitated YT521-B using its FLAG-tag ( Fig. 2A, left) . As expected, in the presence of c-Abl, two bands are tyrosine phosphorylated ( Fig. 2A, middle) . The comparison with the western blot probed against YT521-B demonstrates that the lower band corresponds to FLAG-YT521-B ( Fig. 2A, left) . The reblot using an antibody against c-Abl shows that the upper band represents phosphorylated c-Abl ( Fig. 2A, right) . Next, we performed a similar experiment with c-Src (Fig. 2B ) using EGFP-YT521-B. In the presence of c-Src, we observed the tyrosine phosphorylation of YT521-B (Fig. 2B, middle) . Similar to c-Abl, we also detected phosphorylated c-Src in the YT521-B immunoprecipitate (Fig. 2B, middle) , as confirmed by the reblot with anti Src antibody (Fig. 2B, right) . Furthermore, we observed that recombinant c-Abl and c-Src can induce tyrosine phosphorylation of YT521-B generated in reticulate lysates (data not shown). We conclude that YT521-B can bind to c-Abl and c-Src in immunoprecipitation under in vivo conditions.
YT521-B shuttles between nucleus and cytoplasma
YT521-B was phosphorylated by the membrane bound kinases c-Src (Fig. 1 ) and p59 fyn (7) , to which it binds in immunoprecipitation ( Fig. 2) (7) . Since YT521-B is detected only in the nucleus of cells, a phosphorylation by membrane bound kinases would only be possible during mitosis when the nuclear structure disintegrates or would require shuttling of YT521-B between nucleus and cytosol that has been reported for several proteins implicated in splice site selection (45) . To test these possibilities, we assessed the capability of EGFP-YT521-B to shuttle using a previously described cell fusion assay. The assay monitors accumulation of a fluorescent protein in acceptor nuclei of a newly formed polykaryon (46, 47) . Transfected HeLa cells expressing EGFP-YT521-B were fused with an excess of untransfected HeLa cells and accumulation of EGFP-YT521-B in acceptor nuclei monitored by time-lapse imaging. The donor cells were marked with redfluorescent protein to allow distinction from acceptor cells. As shown in Figure 3 , EGFP-YT521-B fluorescence is visible in the acceptor nuclei 28 min after cell fusion and increases by 308 min. Concomitantly, fluorescence intensity of the donor nucleus decreases (see Supplementary Material, movie). No shuttling is observed for GFP-tagged B23 (46) or histone 2B (data not shown) within 360 and 720 min, respectively, in this assay. These results indicate that YT521-B shuttles between nucleus and cytosol, where it could interact with membrane bound src-family kinases.
YT521-B colocalizes with c-Abl in the nucleus
Since c-Abl can coimmuoprecipitate with YT521-B, we next determined whether it colocalizes with YT521-B in the cell. YT521-B is present in a distinct nuclear substructure, the YT bodies (40) . First, we determined the effect of c-Abl expression on overexpressed EGFP-YT521-B. In the absence of overexpressed c-Abl, EGFP-YT521-B is present in 20 -30 nuclear dots, the YT bodies (Fig. 4A ). After cotransfection with c-Abl, these dots dissolve and colocalize with c-Abl in the nucleus ( Fig. 4C and D) . As expected, c-Abl is also present in the cytosol (Fig. 4B) . However, YT521-B is completely absent in the cytosol, demonstrating that overexpression of c-Abl does not induce a translocation of YT521-B into the cytosol (Fig. 4D) . As reported earlier, EGFP-YT521-B generates YT bodies that appear larger then endogenous YT bodies (40) . We therefore determined the influence of c-Abl on endogenous YT521-B localization (Fig. 4E) , employing an antiserum that was previously 
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Human Molecular Genetics, 2004, Vol. 13, No. 15 developed (7, 40) . As shown in Figure 4H , endogenous YT521-B colocalizes with c-Abl in the nucleus, but not in the cytoplasm, where YT521-B is absent. In the presence of c-Abl (Fig. 4F ), the defined YT bodies disperse throughout the nucleoplasm, excluding the nucleoli ( Fig. 4G and H).
Together with the coimmunoprecipitation, these data suggest that YT521-B is a target of c-Abl in the nucleus.
YT bodies disperse after tyrosine phosporylation
The effect of c-Abl on YT521-B is reminiscent of SR-protein kinases that cause dispersion of nuclear speckles containing their target SR-proteins (48) . We therefore asked whether other tyrosine kinases phosphorylating YT521-B have a similar effect. We cotransfected EGFP-YT521-B with Figure 5A , coexpression of YT521-B with these kinases caused dispersion of YT bodies. As in the situation with c-Abl, YT521-B did not leave the nucleus or enter space occupied by nucleoli. Catalytic inactive mutants of p59 fyn or c-Src (FynKA, SrcKA) had no effect, which demonstrates that phosphorylation causes YT body dispersion. Activation of the ras-pathway that ultimately leads to phosporylation of SAM68 had no effect (29) . Similarly, Csk that did phosphorylate some proteins, but not YT521-B (Fig. 1B and  D) did not alter YT body formation (Fig. 5A) . These results indicate that dispersion of YT bodies is dependent on YT521-B phosphorylation. However, we observed differences in nuclear staining after phosphorylation, as small dot-like structures were still visible after phosphorylation with Rlk. We therefore quantified the staining pattern and determined the nuclear space containing YT521-B bodies, diffuse YT521-B-staining and no YT521-B signal. YT bodies were defined as an accumulation of green signal stronger than the double standard deviation of the total signal distribution, which corresponds well with the visual inspection. As shown in Figure 5B , about 10% of the nuclear space is occupied by YT bodies in untreated cells. The presence of kinases reduced this number to 0 -2.7%. The Student's t-test showed that these differences are statistically significant (P , 0.0001). The dispersion of YT bodies is concomitant with a change of the cellular areas where YT521-B is not present. It increases from 35 -50% in untreated cells to 65 -90% in Rlk, c-Src and p59 fyn transfected cells. In contrast, in c-Abl transfected cells, the area free of YT521-B slightly increases to 60%. It is possible that this is an effect of c-Abl overexpression that directs YT521-B to nuclear areas containing AT-rich DNA preferred by c-Abl for binding (43) . These experiments show that the localization of YT521-B in YT bodies is regulated by tyrosine phosphorylation, similar to the localization of SR-proteins in nuclear speckles that is influenced by serine/threonine phosphorylation.
The solubility of YT521-B is regulated by phosphorylation
In the nucleus, YT521-B is present in two biochemically distinguishable compartments (40) . The first compartment is YT bodies, which are soluble under non-denaturing conditions in Triton X-100 containing buffers. The remaining YT521-B protein resides diffusely in the nucleoplasm and is insoluble in Triton X-100 containing buffers. We previously demonstrated that YT521-B can translocate during the cell cycle or after actinomycin D treatment between these two compartments (40) . High concentrations of actinomycin D (50 mg/ml) that block all three RNA polymerases cause complete dispersion of YT bodies and the accumulation of YT521-B in the Triton X-100 insoluble nuclear fraction (40) . We therefore tested whether tyrosine phosphorylation of EGFP-YT521-B would also result in the accumulation of the protein in an insoluble nuclear fraction. We transfected EGFP-YT521-B into HEK293 cells and analyzed its solubility in a 1% Triton X-100-based cell lysis buffer (HNTG). As shown in Figure 6 , in the presence of c-Abl, c-Src or p59 fyn , EGFP-YT521-B was present in the Triton insoluble pellet (P) fraction (Fig. 6A) . In contrast, when we used a RIPA/benzonase buffer, the protein was present in the soluble (S) fraction (Fig. 6B) , demonstrating that the protein is not covalently bound. This effect is dependent on YT521-B phosphorylation, as the presence of Csk that does not phosphorylate YT521-B, but does phosphorylate other proteins had no effect ( Fig. 1B and D) . Next, we determined whether endogenous YT521-B showed a similar response to tyrosine phosphorylation and analyzed its solubility in the presence of c-Abl, p59 fyn and c-Src. As shown in Figure 6C , phosphorylation by these kinases resulted in YT521-B accumulation in a Triton X-100 insoluble compartment. Again, the phosphorylated protein was soluble in RIPA/benzonase containing buffer (Fig. 6D) . We conclude that the tyrosine phosphorylation of YT521-B causes its association with insoluble nuclear structures.
YT521-B acts on the interleukin-4 receptor pre-mRNA YT521-B has been shown to influence alternative splice site selection in vivo (7). Therefore, we wanted to investigate whether tyrosine phosphorylation would alter the ability of YT521-B to change splice site selection. Alternative splicing of the interleukin 4-receptor is regulated at least in part by tyrosine phosphorylation events emanating from stimulation of the IL-4 receptor by IL-4 (49). Due to alternative splicing and incorporation of an in-frame stop codon, a soluble and a membrane bound form of the IL-4 receptor are formed. The soluble form has no effect in mediating the IL-4 signal to the cell. We constructed a IL-4 receptor minigene comprising the alternative exon 8 of the mouse IL-4 receptor flanked by the constitutive exons 7 and 9 (50) using standard methods (51) . The minigene cassette was cloned between the insulin exons of an exon-trap vector (Fig. 7A) . First, we investigated whether YT521-B interacts with the IL-4 receptor mRNA in vivo. This is likely, because YT521-B binds to SAM68, rSLM-2, hnRNP G and SAF-B in vivo. All these proteins have been implicated in splice site selection (7) . Furthermore, YT521-B can possibly bind nucleic acids via its YTH domain (8) . We immunoprecpitated EGFP-YT521-B in the presence of the IL-4R minigene and detected RNA present in the precipitates by RT -PCR (52) using IL-4 receptor minigene specific primers. The amplification of IL-4 receptor variants demonstrates that YT521-B associates with this mRNA and can possibly regulate it (Fig. 7B) . The presence of c-Abl reduced the amount of RNA found in the immunoprecipitates (Fig. 7B, lanes 1 and 2) , although similar amounts of EGFP-YT521-B were present in the precipitates (data not shown). Sequencing of the products revealed that they were intermediates of the IL-4 receptor pre-mRNA processing (Fig. 7B) . Interestingly, one of the products, band a, was generated by retention of intron D (Fig. 7A) . To determine whether such an intron retention event occurs in vivo, we amplified RNA from various lymphocytes expressing the ILR receptor using an intron-specific primer. As shown in Figure 7C , mRNA with intron D retention is expressed in L1/1 and CTLL-2 cells (53) . These data show that YT521-B interacts with the IL-4R pre-mRNA.
Phosphorylation changes the ability of YT521-B to influence splice site selection of the interleukin 4 pre-mRNA Next, we determined whether YT521-B influences splice site selection of the IL-4R pre-mRNA. We analyzed IL-4R alternative splicing pattern dependency on YT521-B concentration by cotransfection and RT-PCR (51), using primers in the flanking constitutive insulin exons. Transfection of the IL-4R minigene in HEK239 resulted in a variant that predominantly skips the alternative exon 8 (Fig. 8A, lane 1) . The cotransfection of c-Abl does not change the splicing pattern (Fig. 8A, lane 5) when no exogenous YT521-B is present. However, an increase in the concentration of YT521-B by cotransfection promotes retention of intron D in a dose dependent manner (Fig. 8A, lanes 2 -4) . The presence of c-Abl significantly reduces this influence of YT521-B on alternative splice site selection (Fig. 8A, lanes 6 -8) . Western blots of immunoprecipitations made in parallel experiments confirmed the dose dependent increase of YT521-B (Fig. 8B ) and verified that YT521-B was phosphorylated by c-Abl (Fig. 8C) . Quantification of the RT -PCR experiments (Fig. 8D) revealed that the c-Abl evoked differences were statistically significant (t-test: P , 0.0001, P , 0.006) for 2 and 3 mg transfected EGFP-YT521-B, respectively (Fig. 8D) . The observed 2-to 3-fold effect is comparable with the 1.5-to 4-fold effects of phosphorylation on splice site selection observed in vivo (21, 31, 54, 55) . To rule out that this is an unspecific tyrosine phosphorylation effect, we performed the same experiment in the presence of an expression clone for Sik, which does not phosphorylate YT521-B (Fig. 1B) , but acts on nonidentified cellular proteins (Fig. 1D) . As shown in Figure 8E , Sik does not influence the YT521-B mediated changes in alternative splicing. We conclude that tyrosine phosphorylation of YT521-B changes its influence on IL-4R splice site selection. The phosphorylation dependency of the localization of YT521-B (Figs 5 and 6) suggests that changes in local concentration and solubility of YT521-B are responsible for these effects.
Phosphorylation changes the ability of YT521-B to influence CD44 and SRp20 alternative pre-mRNA splicing
To test whether the dependency of YT521-B function on its phosphorylation status is present in other systems, we tested two more minigenes. We employed the CD44 exon v5 minigene ( Fig. 9A ) that is dependent on the YT521-B interacting proteins rSLM-2 and SAM68 (28, 29, 56) , as well as the SRp20 minigene pXB MG (Fig. 9D ) that is regulated by YT521-B (7). As shown in Figure 9B , an increase of the concentration of YT521-B reduces inclusion of the alternative exon CD44 v5 in a concentration dependent manner. This dependency is partially abolished by c-abl induced phosphorylation, as c-abl does not influence the effect of small concentrations of YT521-B (Fig. 9B, lanes 2 and 6) , but blocks the further increase of exon skipping promoted by YT521-B (Fig. 9B, lanes 3, 4 and 7, 8 , and C). Similarly, phosphorylation modulates the effect of YT521-B on SRp20 alternative splicing. As shown in Figure 9E , lanes 1 and 5, in the presence of c-abl, exon 4 inclusion is increased, even when no additional YT521-B is transfected. It is possible that c-abl acts here on endogenous YT521-B. The presence of c-abl reduces the ability of YT521-B to decrease exon 4 usage 2-to 4-fold (Fig. 9E, lanes 2 -4, 6-8, and F) . Together, these data show that tyrosine phosphorylation modulates the influence of YT521-B on splice site selection of several pre-mRNAs.
DISCUSSION
Tyrosine-phosphorylation regulates the nuclear localization of YT521-B
An increasing number of specialized domains have been described for the nucleus. In several cases, these domains have been shown to be highly dynamic structures that respond to stimulation, changes in cell cycle, malignant transformation or DNA damage (reviewed in 1,4,57 -59). The experiments described here show that the intranuclear distribution of YT521-B is dependent on its tyrosine phosphorylation status. Non-phosphorylated YT521-B is predominantly located in YT bodies, nuclear structures that contain focal sites of transcription and partially overlap with SC35 nuclear speckles (40) . YT bodies are soluble in non-denaturing buffers. Tyrosine phosphorylation of YT521-B changes that distribution and solubility. It causes diffuse nuclear appearance of YT521-B and its tight association with an insoluble nuclear fraction. The release of YT521-B from YT bodies after tyrosine phosphorylation is reminiscent of the dispersion of nuclear speckles after serine/threonine phosphorylation of their proteins through cdc2 like kinases or SR-protein kinases (48,60 -62) . Functionally, serine/threonine phosphorylation of splicing factors can change splice site selection (17, 63) by changing phosphorylation dependent proteinprotein interactions (64) . Since c-Abl causes YT521-B phosphorylation, colocalizes with it and binds tightly to it in immunoprecipitations, we propose that YT521-B is a novel nuclear target for c-Abl. It is possible that the first association between c-Abl and YT521-B is mediated by the proline rich region of YT521-B and the SH3 domain of c-Abl. Tyrosine phosphorylation would then stabilize the binding by phosphotyrosine -SH2 domain interaction. Several other non-receptor tyrosine kinases do not phosphorylate YT521-B, indicating a specific interaction between c-Abl and YT521-B. It is well established that RNA polII CTD is phosphorylated by c-Abl (65) . Since YT bodies contain transcriptional start sites, it is possible that c-Abl phosphorylates YT521-B and RNA polII in the same nuclear compartment. The activity of nuclear c-Abl is controlled during the cell cycle via interaction with pRB (66) . The cyclin dependent hyperphosphorylation of pRB releases binding to c-Abl and activates the kinase at the S-phase. This correlates with the finding that YT bodies cannot be detected during S-phase and form at the entrance of G1 (43, 66) . It also explains why YT bodies are markers for differentiated cells and are less pronounced in rapidly dividing transformed cells (40) . In contrast to the CTD (65), YT521-B is phoshorylated by src family kinases. We observed shuttling of YT521-B between the nucleus and the cytosol, which shows that the protein can contact the membrane bound src-family kinases c-Src and p59 fyn that phosphorylate YT521-B and bind to it tightly. It is therefore likely that these kinases can directly phosphorylate YT521-B and influence its properties. Computer programs predict 22 possible tyrosine phosphorylation sites in YT521-B. It remains to be determined which sites are responsible for the localization effects. The exact mechanism of actinomycin D influence on YT body localization remains to be determined as well. We did not observe a general increase in tyrosine phosphorylation after actinomycin D treatment, but cannot rule out the phosphorylation of specific proteins. Since YT521-B is insoluble after this treatment, it is not possible to determine whether it is phosphorylated. It is possible that actinomycin D causes a disruption of the nuclear matrix due to changes in DNA structure and RNA polymerase activity.
Human Molecular
Similarities between effects of tyrosine phosphorylation in the cell membrane and the nucleus After tyrosine phosphorylation, YT521-B changes its binding properties and associates with an insoluble nuclear structure. There are several parallels between the behavior of YT521-B and membrane bound receptor tyrosine kinases that form large signaling complexes after phosphorylation using scaffolding adaptors. First, in both cases tyrosine phosphorylation induces binding to other proteins. After phosphorylation, YT521-B binds tightly to c-Abl, most likely to the c-Abl SH2-domain. Secondly, the complex formation induced by phosphorylation changes the function of the molecules. Membrane bound receptor tyrosine kinases gain signaling function in the activated complexes, whereas YT521-B seems to lose its function in splice site regulation. It is not clear, however, whether there are nuclear scaffolding adaptor proteins in non-transformed cells. One possibility is that DNA or RNA present in the nuclear matrix serves as such an adaptor. All interacting proteins of YT521-B can bind to RNA, or to both RNA and matrix attachment region DNA (7). Biochemically, benzonase is needed to effectively solubilize phosphorylated YT521-B, which suggest an involvement of nucleic acids. Finally, there is no YT521-B ortholog in yeast or bacteria, suggesting that, similar to receptor tyrosine kinases (67), YT521-B is characteristic for metazoans.
Splice site selection is regulated by tyrosine phosphorylation
A functional consequence of YT521-B phosphorylation is to modulate the influence of YT521-B on splice site selection. YT521-B binds to several proteins implicated in splice site selection, which it can change in a concentration dependent manner (7). In the IL-4 receptor system that we used, YT521-B causes intron retention, which is a frequent form of alternative splicing occurring in an estimated 6% of all alternative splicing events (68) . The retention of the intron between exon 9 and 10 can be detected in lymphocytes, indicating that it is a physiological event. However, the form is clearly low abundant in cells, especially when compared with the results from minigene transfection. This low abundance can be explained by in frame stop codons present in the intron that destine the mRNA to nonsense-mediated decay. RNA derived from minigenes most likely escapes nonsense-mediated decay because it is not translated, which explains the difference between minigene transfections and endogenous RNA. Phosphorylation changes the influence of YT521-B on splice site selection about 2-to 3-fold, which is comparable with the effects of phosphorylation on splice site selection observed in vivo (21, 31, 54, 55) . We observed a similar influence of phosphorylation on the ability of YT521-B to regulate the alternative cassette exons in CD44 and SRp20. This shows that this mechanism regulates not only intron retention, but also other modes of alternative splicing.
Non-phosphorylated YT521-B colocalizes with transcriptional start sites and shows overlapping localization with nuclear speckles (40) . There, its most likely function is to bind nascent mRNA via its YTH domain (8) or to form specific mRNA -protein complexes that bridge splice sites (69, 70) . As with other splicing factors, interactions between YT521-B and other proteins functioning in pre-RNA processing is intrinsically weak (7). This allows for dynamic association and reassociation to the nascent pre-mRNA -protein complexes. Such a dynamic behavior is only possible when the protein is soluble. As a consequence, non-phosphorylated YT521-B can regulate splice sites in a concentration dependent manner. Phosphorylation results in such a strong association between YT521-B and nuclear structures that buffer conditions have to be used for solubilization which destroy all protein interactions of non-phosphorylated YT521-B. Furthermore, phosphorylated YT521-B is dispersed through the nucleus and removed from the vicinity of actively transcribed genes. Due to its insolublitity and spatial distance, phosphorylated YT521-B is effectively removed from pre-mRNA processing events in the cell and can no longer influence splice site selection. A similar phosphorylation-dependent redistribution of nuclear splicing factors has been demonstrated for SF2/ ASF (45) , where serine/threonine phosphorylation induced by the Clk/Sty kinases causes accumulation of SF2/ASF in the cytosol. Interestingly, the phosphorylation affects mainly the localization of proteins, but not their ability to change splice sites in vitro (71) . Serine/threonine phosphorylation under stress conditions (22) or hypoxia (23) causes hyperphosphorylation and accumulation of SR-proteins or hnRNPs in the cytosol. This could serve the similar purpose of removing factors from pre-mRNA processing events. In fact, in vivo, splice site selection is altered after application of osmotic stress or hypoxia (22, 23) . Using cotransfection assays, we previously demonstrated that sequestration of splicing factors can regulate splice site selection (17) . Although this mechanism The ratio between the signal corresponding to exon inclusion and all products was determined from at least three different independent experiments. Stars indicate statistical significant differences (P ¼ 0.0007 and P ¼ 0.001, for 2 and 3 mg, respectively). can explain differences in splice site selection between tissues with different concentration of regulatory proteins, it cannot account for rapid changes in splice site selection after cellular stimulation (31) . We propose that phosphorylation dependent sequestration of YT521-B in an insoluble state is a mechanism to regulate splice site selection in response to a kinase signal. After phosphorylation, YT521-B is localized in nuclear regions distant from the areas where transcription and premRNA processing occurs. The phosphorylated protein is insoluble and most likely not able to participate in the dynamic rearrangement of protein complexes necessary for splice site recognition. This mechanism allows the cell to temporarily lower the active concentration of YT521-B without destroying the protein. The mechanism partially explains the frequently observed changes of splice site selection in malignant transformation (72) and during development (11) , as these processes are triggered or are concomitant with an increase in receptor tyrosine phosphorylation. It implies that in addition to the combination of splicing factors (15) the tyrosine phosphorylation status of splicing factors can contribute to cellspecific alternative splicing.
MATERIALS AND METHODS
Cell culture and transfection
HEK293 and COS7 cells were maintained in DMEM supplemented with 10% fetal calf serum (GibcoBRL). For immunolabeling experiments, cells were grown on glass coverslips in 3.5 cm cell culture dishes. The day before transfection, 3.0 Â 10 5 HEK293 cells per 3.5 cm plate were seeded in 3 ml of DMEM and 10% FCS and incubated at 378C in 5% CO 2 for 24 h. Transient transfections of adherent HEK293 cells with cDNAs were performed using the calcium precipitation as described (51) . COS7 cells were transfected 24 h after seeding using Superfect (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Plasmids encoding for EGFP-YT521-B, FLAG-YT521-B contained the full length rat cDNA with N-terminal tags and were described earlier (7), as well as expression constructs for c-Abl (human), Csk, c-Fyn, c-FynKA, c-Src and c-SrcKA (7). FerH expressed from pHUG10 -3 (Fer) was generously supplied by N. Heisterkamp (73), Rlk from pcDNA3-RLK from P.L. Schwartzberg (42), Sik was provided by A.L. Tyner (74), Syk from pSVL-Syk from J. Zhang (75) .
Immunoprecipitation and western blotting
Twenty-four hours after transfection, cells were lysed in 200 ml of radioimmunoprecipitation assay (RIPA) buffer (1% NP40, 1% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 10 mM Na-phosphate, pH 7.2, 2 mM EDTA, 50 mM NaF, 5 mM b-glycerolphosphate, and freshly added 4 mM sodium orthovanadate, 1 mM DTT, 1 mM PMSF, 20 mg/ml aprotinin, and 100 U/ml benzonase) for 30 min on ice. Precipitates were cleared by centrifugation. Lysates were diluted 4-fold in RIPA rescue (20 mM NaCl, 10 mM Na-phosphate, pH 7.2, 1 mM NaF, 5 mM b-glycerolphosphate, and freshly added 2 mM sodium orthovanadate, 1 mM DTT, 1 mM PMSF, and 20 mg/ml aprotinin). Immunoprecipitations were performed overnight at 48C with agitation using anti GFP (Roche) or anti FLAG (Sigma) antibodies and protein A-Sepharose (Pharmacia; protein A-Sepharose : Sepharose, 1 : 1, resuspended in RIPA rescue buffer), followed by three washes in 50 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM EDTA, 10% glycerol, 0.1% Triton X-100, and freshly added 2 mM sodium orthovanadate, 100 mM NaF, 1 mM PMSF, and 20 mg/ml aprotinin. The proteins were subsequently analyzed on 7.5 or 10% SDS -polyacrylamide gels followed by western blotting and ECL. Anti GFP (Roche), antiphosphotyrosine 4G10 (Santa Cruz), anti-YT521-B (40), Anti Abl (21 -11, Santa Cruz), FLAG M2 (Sigma) and anti Src antibodies (pp60src, Biomol, Germany) were used according to the manufacturer's instructions. Anti YT521-B (PK2) was described earlier (40) .
Protein shuttling
Protein shuttling was essentially performed as described (46) . 
Solubility assay
The solubility assay was previously described (60) . Twentyfour hours after transfection, cells were lysed for 30 min on ice in 200 ml buffer containing 50 mM Hepes, pH 7.5, 150 mM NaCl, 1% Triton X-100, 10% glycerol, 1 mM EDTA, 20 mM sodium pyrophosphate, 2 mM sodium orthovanadate, 100 mM NaF, 5 mM ß-glycerophosphate, 1 mM PMSF and 1 mg/ml aprotinin (HNTG buffer). The lysates were centrifuged at 13 000g for 15 min at 48C, 100 ml 3Â SDS sample buffer was added to the supernatant, and 300 ml 3Â SDS sample buffer was added to the remaining pellet. The probes were mixed, boiled for 5 min, and 30 ml of each fraction loaded onto 10% SDS -polyacrylamide gels. Alternatively, cells were lysed for 30 min on ice in 200 ml RIPA buffer (0.01 M sodium phosphate, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS, 0.15 M NaCl, 2 mM EDTA, 1 mM NaF, 4 mM sodium orthovanadate, 5 mM ß-glycerolphosphate, 1 mM PMSF, 1 mg/ml aprotinin, and 100 U/ml benzonase). Lysates were centrifuged for 15 min at 48C, 100 ml 3Â SDS sample buffer was added to the supernatant, and 300 ml 3Â SDS sample buffer was added to the pellet. An aliquot of 30 ml of the fraction was loaded in each lane and analyzed on 10% SDS -polyacrylamide gels. The proteins were analyzed by western blotting and ECL using anti-GFP (Roche) and PK2 antibodies.
Immunostaining
Cells were fixed in 4% formaldehyde and PBS for 10 min at 48C, washed three times in PBS and 0.1% Triton X-100, and blocked in PBS, 0.1% Triton X-100, and 3% NGS for 2 h at room temperature. Cells were then incubated with the appropriate antibody (diluted in PBS, 0.1% Triton X-100, and 3% bovine serum albumin) overnight at 48C and washed three times in PBS and 0.1% Triton X-100. Cells were then incubated with CY3-or FITC-coupled secondary antibody (Dianova) in PBS and 0.1% Triton X-100 for 2 h at room temperature, washed three times in PBS and 0.1% Triton X-100, and mounted on glass slides in Fluormount (Dianova). The cells were examined by laser scanning fluorescent microscopy (Leica).
Quantification of cell staining
Cells were analyzed with confocal microscopy and single images were analyzed using Photoshop. First the cell nucleus was outlined. Next, YT bodies were marked through visual inspection and the mean of their integrated signals 2 standard deviations was calculated as YT bodies. The black areas were marked by visual inspection and the mean of their integrated distribution þ standard deviation was designated as areas void of YT521-B. The remaining area was defined as dispersed YT521-B staining.
RNA immunoprecipitation
Cells were trypsinated 36 h after transfection and washed in 30 vol of PBS and resuspended in one packed cell volume of buffer A (10 mM HEPES, pH 8.0, 1.5 mM MgCl 2 , 10 mM KCl, 1 mM DTT) and allowed to swell on ice for 15 min. Cells were lysed with a 23G hypodermic needle and nuclei were recovered by 20 s centrifugation at 12 000g at RT. The crude nuclear pellet was resuspended in two-thirds of one packed cell volume of buffer C [20 mM HEPES, pH 8.0, 25% (v/v) glycerol, 420 mM NaCl, 0.2 mM EDTA, pH 8.0, 1 mM DTT, 0.5 mM PMSF] and incubated at 48C with stirring for 30 min. The nuclear debris was pelleted by 5 min centrifugation at 12 000g. Collected nuclei were resuspended in 0.6 ml of NET-Triton (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 0.1% Triton X-100, protease inhibitors), pushed through a narrow-gauge needle and centrifuged. Immunoprecipitation with anti GFP antibody and protein A Sepharose was performed overnight at 48C on the supernatant, followed by five washes with cold RIPA buffer. RNA was isolated using the Trizol (Invitrogen) reagent. After ethanol precipitation the RNA pellet was dissolved in RNase-free water.
In vivo splicing assay
In vivo splicing was performed as described (51) . Briefly, 1 mg of the reporter gene was transfected together with an increasing amount (0, 1, 2 and 3 mg) of YT521-B-construct and 0.5 mg of c-Abl plasmid in 300 000 HEK293 cells using the calcium phosphate method. Empty vector (pEGFP-C2) was added to ensure that equal amounts of DNA were transfected. Transfection was performed at 378C in 3% CO 2 overnight. RNA was isolated 17 h after transfection using an RNeasy mini kit (Qiagen), following the manufacturer's instructions. RNA was eluted in 40 ml of RNase-free H 2 O. For reverse transcription, 2 ml of isolated RNA were mixed with 5 pmol of antisense minigene-specific primer in 0.5 ml H 2 O, 2 ml of 5Â RT buffer, 1 ml of 100 mM DTT, 1 ml of 10 mM dNTP, 3 ml of H 2 O, 0.25 ml of RNase inhibitor and 0.2 ml of SuperScriptII (Invitrogen). The tubes were incubated for 45 min at 428C. Aliquots of 1 ml of the RT reaction were mixed with 2.5 pmol of sense and antisense primer each, 10Â PCR reaction buffer, 200 mM dNTP and 0.2 ml Taq-polymerase.
For the IL4R minigene, the PCR conditions were initial denaturation for 2 min at 948C; 35 cycles: 30 s denaturation at 948C, combined annealing and extension at 728C for 90 s, after 35 cycles a final extension at 728C for 20 min and cooling to 48C in a Perkin-Elmer thermocycler. The PCR reaction products were analyzed on a 2% agarose Tris borate-EDTA gel of thickness 0.3-0.4 cm.
